Published online before print June 15, 2006, doi: 10.1161/01.RES.0000232324.87983.4b
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2006 American Heart Association, Inc.
Clinical Research |
Haplotypes of the Caspase-1 Gene, Plasma Caspase-1 Levels, and Cardiovascular Risk
From the Departments of Medicine II (S. Blankenberg, H.J.R., C.B., R.S., T.M.) and Clinical Chemistry and Laboratory Medicine (K.J.L.), Johannes Gutenberg-University Mainz, Germany; INSERM U525 (T.G., O.P., S. Barbaux, V.N., F.C., L.T.), Université Pierre et Marie Curie/Faculté de Médecine Pitié-Salpêtrière, Paris, France; Department of Epidemiology and Public Health (F.K., A.E.), Belfast, UK; and Greater Glasgow Health Board (C.M.), Glasgow, UK.
Correspondence to Stefan Blankenberg, Department of Medicine II, Johannes Gutenberg-University Mainz, Langenbeckstr 1, 55131 Mainz, Germany. E-mail blankenberg{at}2-med.klinik.uni-mainz.de
Caspase-1 processes the interleukin (IL)-1ß and IL-18 inactive precursors to the biologically active cytokines that are known to have proatherogenic effects. The present study investigated the genetic variability of the CASP1 gene and plasma levels of caspase-1 in relation to cardiovascular risk. In Europeans, 3 tag SNPs captured 4 common haplotypes of the CASP1 gene. Among these, the Ain6 allele of the G+7/in6A polymorphism was less frequent in 246 cases with myocardial infarction and a parental history of disease than in 253 controls free of familial history of disease (0.13±0.02 versus 0.20±0.02; P=0.005). However, in a larger case/control study (n=1774), these effects are borderline restricted to the UK population. In a prospective cohort of 1168 patients with coronary artery disease followed up during a median period of 6.0 years, the Ain6 allele exhibited a borderline association with future cardiovascular death (hazard ratio [HR]: 0.64, 0.41 to 1.01; P=0.053) and was associated with lower serum IL-18 levels (P=0.014). Baseline caspase-1 levels in the top quartile of the distribution were predictive of cardiovascular deaths (HR=3.62, 1.81 to 7.27; P=0.0003 compared with the bottom quartile). Finally, in vitro assays of allelic imbalance showed that the CASP1 haplotype carrying the Ain6 allele was associated with a lower mRNA expression. These results indicate that caspase-1 levels are predictive of future cardiovascular death in patients with coronary artery disease. The role of CASP1 genetic variations in the susceptibility to myocardial infarction requires further investigation.
Key Words: caspase-1 • inflammation • prognosis • coronary disease • genetics
This article has been cited by other articles:
 |
|
 |
|
  R. I. Dmitrieva, C. A. Hinojos, M. L. Grove, R. J. Bell, E. Boerwinkle, M. Fornage, and P. A. Doris Genome-Wide Identification of Allelic Expression in Hypertensive Rats Circ Cardiovasc Genet, April 1, 2009; 2(2): 106 - 115. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Yajima, M. Takahashi, H. Morimoto, Y. Shiba, Y. Takahashi, J. Masumoto, H. Ise, J. Sagara, J. Nakayama, S. Taniguchi, et al. Critical Role of Bone Marrow Apoptosis-Associated Speck-Like Protein, an Inflammasome Adaptor Molecule, in Neointimal Formation After Vascular Injury in Mice Circulation, June 17, 2008; 117(24): 3079 - 3087. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Trompet, A. J. M. de Craen, P. Slagboom, J. Shepherd, G. J. Blauw, M. B. Murphy, E. L. E. M. Bollen, B. M. Buckley, I. Ford, A. Gaw, et al. Genetic variation in the interleukin-1{beta}-converting enzyme associates with cognitive function. The PROSPER study Brain, April 1, 2008; 131(4): 1069 - 1077. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Schunkert, A. Gotz, P. Braund, R. McGinnis, D.-A. Tregouet, M. Mangino, P. Linsel-Nitschke, F. Cambien, C. Hengstenberg, K. Stark, et al. Repeated Replication and a Prospective Meta-Analysis of the Association Between Chromosome 9p21.3 and Coronary Artery Disease Circulation, April 1, 2008; 117(13): 1675 - 1684. [Abstract] [Full Text] [PDF]
|
|